ATE505535T1 - Verfahren zur herstellung stabiler b-lymphozyten - Google Patents

Verfahren zur herstellung stabiler b-lymphozyten

Info

Publication number
ATE505535T1
ATE505535T1 AT06842246T AT06842246T ATE505535T1 AT E505535 T1 ATE505535 T1 AT E505535T1 AT 06842246 T AT06842246 T AT 06842246T AT 06842246 T AT06842246 T AT 06842246T AT E505535 T1 ATE505535 T1 AT E505535T1
Authority
AT
Austria
Prior art keywords
lymphocytes
producing stable
producing
stable
methods
Prior art date
Application number
AT06842246T
Other languages
English (en)
Inventor
Herman Groen
Hans Westra
Original Assignee
Iq Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iq Corp filed Critical Iq Corp
Application granted granted Critical
Publication of ATE505535T1 publication Critical patent/ATE505535T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06842246T 2005-08-23 2006-08-23 Verfahren zur herstellung stabiler b-lymphozyten ATE505535T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71062605P 2005-08-23 2005-08-23
PCT/IB2006/003670 WO2007063415A2 (en) 2005-08-23 2006-08-23 Methods of producing stable b-lymphocytes

Publications (1)

Publication Number Publication Date
ATE505535T1 true ATE505535T1 (de) 2011-04-15

Family

ID=37968195

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06842246T ATE505535T1 (de) 2005-08-23 2006-08-23 Verfahren zur herstellung stabiler b-lymphozyten

Country Status (6)

Country Link
US (2) US20070065919A1 (de)
EP (1) EP1928999B1 (de)
AT (1) ATE505535T1 (de)
CA (1) CA2619784A1 (de)
DE (1) DE602006021324D1 (de)
WO (2) WO2007049152A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2367322T3 (es) * 2005-12-16 2011-11-02 Ribovax Biotechnologies Sa Métodos para obtener células inmortalizadas que secretan anticuerpos.
WO2009020923A1 (en) 2007-08-03 2009-02-12 Musc Foundation For Research Development Human monoclonal antibodies and methods for producing the same
WO2009105150A2 (en) 2008-01-28 2009-08-27 Thomas Jefferson University Method of making hybrid cells that express useful antibodies
US8703486B2 (en) 2008-09-23 2014-04-22 UNIVERSITé LAVAL Method for polyclonal immunoglobulin G production by human B cells
US20110129460A1 (en) * 2009-01-14 2011-06-02 IQ Therapeutics B.V. Combination Antibodies For The Treatment And Prevention Of Disease Caused By Bacillus Anthracis And Related Bacteria And Their Toxins
US9260517B2 (en) 2009-11-17 2016-02-16 Musc Foundation For Research Development Human monoclonal antibodies to human nucleolin
JP7026634B2 (ja) 2016-03-30 2022-02-28 エフ．ホフマン－ラ ロシュ アーゲー Ｂ細胞培養法
GB2569463A (en) 2016-07-18 2019-06-19 Harvard College Human lymphoid tissue-on-chip
EP3562936B1 (de) 2017-01-02 2024-05-22 F. Hoffmann-La Roche AG Verfahren zur kultivierung von b-zellen
EP3625332B1 (de) 2017-05-19 2022-02-02 F. Hoffmann-La Roche AG Verfahren zur herstellung von thymocytüberstand
EP3717632B1 (de) 2017-11-30 2022-10-26 F. Hoffmann-La Roche AG Verfahren zur kultivierung von b-zellen
WO2021027057A1 (zh) * 2019-08-15 2021-02-18 成都冕康生物科技有限公司 一种针对ebv病毒抗原的b细胞疫苗及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126259A (en) * 1987-12-24 1992-06-30 Takeda Chemical Industries, Ltd. Human b. lymphoblastoid cell, hybridoma, antibody and production of antibody
JPH02131574A (ja) * 1988-06-17 1990-05-21 Biogenex Lab ミニクローン
WO1990000404A1 (en) * 1988-07-15 1990-01-25 United Biotech, Inc. Enrichment of antigen-specific polyclonal antibodies through selection of immortal hybrid cells
DE69126281T2 (de) 1990-11-26 1997-10-16 Akzo Nobel Nv Verfahren zur Herstellung von Antikörpern
DE4134297A1 (de) * 1991-10-17 1993-04-22 Behringwerke Ag Monoclonale antikoerper gegen mycoplasma pneumoniae, diese produzierende hybridome, verfahren zu deren herstellung sowie deren verwendung
DE69329642T3 (de) * 1992-03-19 2009-05-20 Henry M. Jackson Foundation For The Advancement Of Military Medicine Breitreaktive opsonische antikörper die mit gemeinsamen antigenen von staphylococcus reagieren
ATE309267T1 (de) 1994-04-28 2005-11-15 Boehringer Ingelheim Pharma Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
FI98493C (fi) * 1994-06-10 1997-07-10 Olavi Kajander Kasvutekijävalmiste, menetelmä sen valmistamiseksi ja käyttämiseksi ja sitä sisältävä elatusaine
US7115264B2 (en) * 2001-11-05 2006-10-03 Inhibitex Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
US7169903B2 (en) * 2001-12-21 2007-01-30 Biosynexus Incorporated Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
EP1891113A2 (de) * 2005-06-02 2008-02-27 AstraZeneca AB Gegen cd20 gerichtete antikörper und ihre verwendung

Also Published As

Publication number Publication date
WO2007063415A3 (en) 2007-11-01
EP1928999A2 (de) 2008-06-11
US20070098711A1 (en) 2007-05-03
WO2007049152A3 (en) 2007-10-04
CA2619784A1 (en) 2007-06-07
WO2007063415A2 (en) 2007-06-07
WO2007049152A2 (en) 2007-05-03
EP1928999B1 (de) 2011-04-13
US7807415B2 (en) 2010-10-05
DE602006021324D1 (de) 2011-05-26
US20070065919A1 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
DE602004009676D1 (de) Verfahren zur Musikklassifikation
ATE464908T1 (de) Verfahren zur behandlung von osteoarthritis mit anti-il-6 antikörpern
DE602006012274D1 (de) Verfahren und Vorrichtung zur Herstellung von Gruppe III Nitridkristall.
ATE440888T1 (de) Verfahren zur herstellung von glatiramer
ATE546524T1 (de) Verfahren zur herstellung aktiver scfv-antikörper und bibliotheken dafür
DE602005007219D1 (de) Verfahren und Vorrichtung zur Trennung von Schallquellensignalen
ATE349408T1 (de) Verfahren zur herstellung verzweigter kohlenwasserstoffe
DE602005019848D1 (de) Verfahren zur herstellung von tad- getrocknetem ti
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
EP1916302A4 (de) Verfahren zur herstellung von lymphozyten
DE602006021324D1 (de) Verfahren zur herstellung stabiler b-lymphozyten
EP1940864A4 (de) Verfahren zur erzeugung monoklonaler antikörper mit antivariabler region
ATE437906T1 (de) Verfahren zur herstellung von pfropfpolymerisaten
ATE486841T1 (de) Verfahren zur herstellung von pregabalin und salzen daraus
DE602006013151D1 (de) Verfahren zur herstellung von polymermaleimiden
ATE544783T1 (de) Neutralisierende anti tlr4/md-2 antikörper und verfahren zu deren verwendung
DE602005019156D1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE502005001997D1 (de) Verfahren zur herstellung von silanisierten kohlenstoff-nanoröhren
DE602005012211D1 (de) Verfahren zur Herstellung von Flugtriebwerksgehäusen mit Flanschen
ATE349442T1 (de) Verbessertes verfahren zur herstellung von alpha- polymorphem eletriptan hydrobromid
ATE459610T1 (de) Verfahren zur herstellung von alkenylbernsteinsäureanhydriden
DE602004023238D1 (de) Methoden zur Kultivierung von Antigen presentierenden Immunzellen
ATE501282T1 (de) Verfahren zur herstellung von konzentraten
DE102005025040B4 (de) Verfahren und Vorrichtung zur Erzeugung von methanreichem Biogas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties